Quick Answer
Cellectar Biosciences, Inc. reported Common Stock Shares Outstanding of 4.24 million shares for the year ending 2025.
- Cellectar Biosciences, Inc. showed an increase of +176.1% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Cellectar Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), Cellectar Biosciences, Inc.'s Common Stock Shares Outstanding has declined by 66.9%.
- Historical annual values: Fiscal year 2025: 4.24 million shares | Fiscal year 2024: 1.54 million shares | Fiscal year 2023: 20.74 million shares | Fiscal year 2022: 9.39 million shares | Fiscal year 2021: 6.11 million shares | Fiscal year 2020: 45.44 million shares | Fiscal year 2019: 9.39 million shares | Fiscal year 2018: 4.73 million shares | Fiscal year 2017: 1.67 million shares | Fiscal year 2016: 10.37 million shares | Fiscal year 2015: 858,140 shares | Fiscal year 2014: 756,276 shares | Fiscal year 2013: 2.87 million shares | Fiscal year 2012: 46.40 million shares | Fiscal year 2011: 36.91 million shares | Fiscal year 2010: 12.82 million shares.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: